One of Montana’s largest health clinics that serves people in poverty has cut back services and laid off workers.
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia | Psychedelic Invest
Silo dosage and time-release formulation aim for potential first at-home Ketamine therapeutic Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a developmental stage biopharmaceutical company